Chiesi Global Rare Diseases Launches New Research Grant Initiative to Support Research Excellence in Lysosomal Storage Disorders

Contributed by: PR Newswire

Images

PR Newswire associated0

Tags

Chiesi-Research

More Like This

Business Wire logo

Chiesi Global Rare Diseases Awards Research Grants to Advance Innovation in Lysosomal Diseases

Chiesi Group Enters into Worldwide Licensing Agreement with Key2Brain AB to Advance Blood-Brain Barrier-Crossing Therapies for Lysosomal Storage Disorders

Oxford-Harrington Rare Disease Centre Opens 2025 Call for Proposals

PR Newswire associated0

Pierre Fabre Laboratories, committed to combating rare pediatric diseases via innovative therapies

PR Newswire associated0

Chiesi Global Rare Diseases and Protalix BioTherapeutics Announce Validation of Variation Submission by European Medicines Agency for pegunigalsidase alfa

Azafaros Secures € 132M in Oversubscribed Series B Financing to Advance Phase 3 Clinical Programs of Innovative Therapies in Lysosomal Storage Disorders

Business Wire logo

Azafaros to Present at BIO International Convention 2025 Following Successful €132M Series B Financing

The Oxford-Harrington Rare Disease Centre (OHC) Announces Inaugural 2024 Rare Disease Scholar Award Recipients